DB
BIOSW

Dmitry Balyasny’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Dmitry Balyasny’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-75,000
Closed -$6.43K – 3082
2023
Q1 		$6.43K Hold
75,000
– – ﹤0.01% 2527
2022
Q4 		$3.45K Hold
75,000
– – ﹤0.01% 2649
2022
Q3 		$11K Hold
75,000
– – ﹤0.01% 2644
2022
Q2 		$8K Hold
75,000
– – ﹤0.01% 2611
2022
Q1 		$17K Buy
+75,000
New +$19.5K ﹤0.01% 2366

Other funds holding BIOSW

PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Dmitry Balyasny's BIOSW Position: Q2 2023 in Review

Dmitry Balyasny sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q2 2023, closing a stake of 75,000 shares — an estimated $6.43K sold.

Dmitry Balyasny first reported a position in BIOSW in Q1 2022 and held it in 5 quarters. The position peaked at $17K in Q1 2022. 44 funds tracked by Wall St. Rank hold BIOSW as of Q2 2023.

  • Dmitry Balyasny reported no remaining BioPlus Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 75,000 BioPlus Acquisition Corp. Warrants shares in Q2 2023, an estimated $6.43K.
  • Dmitry Balyasny first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • Dmitry Balyasny's BioPlus Acquisition Corp. Warrants position peaked at $17K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.